Maxair and Duoneb drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxair (pirbuterol acetate) and Duoneb (albuterol sulfate; ipratropium bromide). Common drug interactions include conjunctivitis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Maxair and Duoneb. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Maxair?

Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,903 Maxair users. Check the latest studies of Maxair.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.



On Jul, 12, 2026

20 people who take Maxair and Duoneb together, and have interactions are studied.

Maxair and Duoneb drug interactions.

What are the common drug interactions of Maxair and Duoneb, by gender? *:

female:

  1. Conjunctivitis (pink eye)
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  3. Injection site erythema (redness at injection site)
  4. Injection site pain
  5. Medical device complication
  6. Muscle atrophy (a decrease in the mass of the muscle)
  7. Oedema peripheral (superficial swelling)
  8. Pain in extremity
  9. Blood pressure increased
  10. Body temperature increased

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Influenza like illness
  3. Anaemia (lack of blood)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Balance disorder
  7. Benign prostatic hyperplasia (benign enlargement of the prostate)
  8. Blood glucose increased
  9. Blood pressure diastolic increased
  10. Blood pressure systolic decreased

What are the common drug interactions of Maxair and Duoneb, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Oedema peripheral (superficial swelling)
  2. Pain
  3. Pain in extremity
  4. Body temperature increased
  5. Chills (felling of cold)
  6. Erythema (redness of the skin)
  7. Eye discharge
  8. Eye injury
  9. Eye swelling
  10. Cellulitis (infection under the skin)

40-49:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Balance disorder
  5. Blood glucose increased
  6. Blood pressure diastolic increased
  7. Blood pressure systolic decreased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Burning sensation
  10. Carbuncle (a carbuncle is an abscess larger than a boil)

50-59:

  1. Anaemia (lack of blood)
  2. Benign prostatic hyperplasia (benign enlargement of the prostate)
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  6. Hepatic steatosis (fatty liver disease)
  7. Hypertension (high blood pressure)
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Lung disorder (lung disease)
  10. Post procedural hypothyroidism

60+:

  1. Dental caries
  2. Hot flush (sudden feelings of heat)
  3. Tooth disorder (tooth disease)
  4. Idiopathic pulmonary fibrosis (chronic lung disease)
  5. Jaw fracture
  6. Nervousness
  7. Oral discomfort (pain or irritation in mouth)
  8. Osteolysis (dissolution of bone)
  9. Pneumonia
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 3 people, 15.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
  3. Spinal Pain (pain in spine): 1 person, 5.00%
  4. Nausea (feeling of having an urge to vomit): 1 person, 5.00%
  5. Lump In The Abdomen (an area of swelling or growth on abdomen): 1 person, 5.00%
  6. Immunodeficiency Common Variable: 1 person, 5.00%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.00%
  9. Essential Hypertension (primary hypertension): 1 person, 5.00%
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Maxair and Duoneb?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxair and Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duoneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pirbuterol acetate and albuterol sulfate; ipratropium bromide (the active ingredients of Maxair and Duoneb, respectively), and Maxair and Duoneb (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: